Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.39
+0.11 (2.08%)
Nov 21, 2024, 12:51 PM EST - Market open

Orchestra BioMed Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
2.652.763.53-0.785.7
Revenue Growth (YoY)
-26.49%-21.88%---
Cost of Revenue
0.190.190.210.20.15
Gross Profit
2.452.573.32-0.985.56
Selling, General & Admin
22.2220.2614.037.9310.83
Research & Development
40.3433.8221.9512.8913.48
Operating Expenses
62.5654.0835.9820.8224.31
Operating Income
-60.11-51.51-32.66-21.8-18.75
Interest Expense
----0.93-
Interest & Investment Income
3.943.850.05-0.33
Other Non Operating Income (Expenses)
-0.01-0.29-1.350.7-0.18
EBT Excluding Unusual Items
-56.17-47.95-33.96-22.03-18.6
Gain (Loss) on Sale of Investments
-0.36-0.021.03-0.99-2.75
Other Unusual Items
-1.15-1.15-0.68--
Pretax Income
-57.69-49.12-33.61-23.01-21.36
Net Income
-57.69-49.12-33.61-23.01-21.36
Net Income to Common
-57.69-49.12-33.61-23.01-21.36
Shares Outstanding (Basic)
36331522
Shares Outstanding (Diluted)
36331522
Shares Change (YoY)
22.34%121.67%609.97%4.86%-
EPS (Basic)
-1.60-1.48-2.24-10.90-10.61
EPS (Diluted)
-1.60-1.48-2.24-10.90-10.61
Free Cash Flow
-48.17-46.21-29.88-19.7-26.72
Free Cash Flow Per Share
-1.33-1.39-1.99-9.33-13.27
Gross Margin
92.71%93.26%94.03%-97.46%
Operating Margin
-2270.68%-1866.16%-924.34%--328.81%
Profit Margin
-2179.34%-1779.71%-951.26%--374.45%
Free Cash Flow Margin
-1819.95%-1674.09%-845.74%--468.56%
EBITDA
-59.81-51.22-32.44-21.62-18.62
D&A For EBITDA
0.30.290.220.180.14
EBIT
-60.11-51.51-32.66-21.8-18.75
Revenue as Reported
2.652.763.53-0.785.7
Source: S&P Capital IQ. Standard template. Financial Sources.